Epigenetics Market Outlook to 2025 : New England Biolabs (NEB), Illumina, Inc, Abcam plc, Agilent Technologies, Active Motif, QIAGEN, Bio-Rad Laboratories, Inc., PerkinElmer Inc, Merck KGaA, Thermo Fisher Scientific, Inc

The "Epigenetics market" report offers an extensive analysis of the market share, forecasts based on key segments, market trends, opportunities, and key strategic moves by market players.

The Insight Partners: DNA methylation Segment is expected to grow the Market for Epigenetics over the Forecast Period for Technology Segment.

Epigenetics Market to 2025 - Global Analysis and Forecasts by Product, Technology, Application and End User. The global epigenetics market is expected to reach US$ 2,611.57 Mn in 2025 from US$ 991.45 in 2017. The market is estimated to grow with a CAGR of 13.6% from 2018-2025. The report highlights the trends prevalent in the global epigenetics market and the factors driving the market along with those that act as deterrents to its growth.

Get Exclusive Sample PDF of Report at http://bit.ly/2T6cPch

The study of heritable changes in gene expression that do not involve changes to the underlying DNA sequence is known as epigenetics. A single or multiple change in phenotype without a changing the genotype which results affects the cells that can read the genes. The report would be of an interest to various stakeholders operating in the epigenetics market. These stakeholders include hospitals, research institutes, medical device suppliers, diagnostic centers, academic institutes, market research, equipment manufacturers, and consulting firms.

The market for epigenetics is expected to grow as declining prices of sequencing, increasing prevalence of cancer, funds & grants provided by government bodies are expected to fuel the market growth during the forecast period. In addition, promising precise treatments by neurogenetics are likely to have a positive impact on the growth of the market in the coming years.

The major players operating in the epigenetics market are Merck KGaA, Thermo Fisher Scientific Inc., ABCAM Plc, Agilent Technologies, Active Motif, Qiagen, Bio-Rad Laboratories, Inc., Perkinelmer Inc., New England Biolabs (NEB), and Illumina Inc.

Key Developments in the Epigenetics Market:
In February, 2018, QIAGEN launches epigenetic breast cancer test in Europe. It is the first clinically validated DNA methylation assay that helps predict the response to anthracycline-based chemo by certain high-risk breast cancer patients.

Order a Copy of this research at http://bit.ly/2T6cTZz

The report segments the global epigenetics market as follows:

Global epigenetics Market - By Product
Reagents
Kits
Enzymes
Instruments & Consumables

Bioinformatics Tools Global epigenetics Market - By Technology
Histone Modification
DNA Methylation
Others

Global epigenetics Market - By Application
Metabolic Diseases
Oncology
Cardiovascular Diseases
Others

Global Epigenetics Market - By End User
Academics & Research Institutes
Contract Research Organizations
Biotechnology & Pharmaceutical Companies

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.